From November 11 to 14, Tianlong, along with KHB and Technogenetics S.P.A. (TGS), showcased at MEDICA 2024 in Düsseldorf, Germany. As one of the world's most influential medical industry exhibitions, MEDICA serves as a critical platform for global healthcare networking and presenting leading-edge technologies and solutions.
A Strong Global Presence: Three Companies Uniting on the International Stage
This MEDICA marks the first time that Tianlong, KHB and TGS have jointly exhibited overseas, presenting innovative solutions across Biochemistry, Immunology, Molecular diagnostics, and POCT. This collaboration demonstrates the group's powerful synergy in healthcare innovation and a shared global vision.
Market Focus: Compact Efficiency and Breakthrough Automation
The innovative products of Tianlong and KHB have garnered strong interest, particularly their compact instruments and all-in-one automated systems. These efficient, convenient devices have become "star products" on site.
Tianlong's Biolum Pro ATP Hygiene Monitoring System, winner of the Red Dot Design Award, was another highlight. This lightweight handheld device delivers hygiene test results in just 10 seconds with high sensitivity, providing quick and precise solutions for food safety and medical applications. Customers noted its versatility for rapid hygiene assessments, tailored to a wide range of client needs.
In addition, Tianlong displayed the Panall 8000 All-In-One Molecular Diagnosis System at this exhibition. Its newly upgraded open system became one of the highlights. "Sample in - result out", Tianlong’s Panall 8000 provides convenient and efficient diagnostic solutions for laboratories with its powerful integrated nucleic acid detection, fully automatic operation and wide compatibility of PCR reagents, which has been highly praised by professionals at the exhibition.
Global Expansion: Strengthening European Presence
MEDICA 2024 provides an excellent opportunity to showcase Tianlong and KHB's core strengths, paving the way for further expansion and strengthening client partnerships. As our global business continues to grow, we will keep enhancing its presence in the European market with advanced technology and localized service.
Looking ahead, we will continue to expand the global business footprint, deepen market penetration, and support clients worldwide in achieving more efficient and accurate diagnostics and treatment.
